Related Experiment Videos
Apoptosis in hypertensive heart disease
J Díez1, M A Fortuño, S Ravassa
1Vascular Pathophysiology Unit, School of Medicine, University of Navarra, Pamplona, Spain.
Insights
Arterial hypertension can lead to heart failure through cardiomyocyte loss, primarily via apoptosis. Understanding the factors triggering this cell death is crucial for preventing heart disease progression.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Molecular Biology
Background:
- Arterial hypertension is a major risk factor for heart failure.
- Systolic dysfunction in hypertension involves cardiomyocyte contractile disturbances, fibrosis, and loss.
- Cardiomyocyte loss is increasingly recognized in the transition to decompensated left ventricular hypertrophy.
Purpose of the Study:
- To explore the role of cardiomyocyte loss in hypertensive heart disease.
- To investigate apoptosis as a mechanism for cardiomyocyte loss in hypertension.
- To identify intrinsic and extrinsic factors that may trigger cardiomyocyte apoptosis.
Main Methods:
- Review of experimental evidence on cardiomyocyte apoptosis in hypertensive hearts.
- Analysis of factors implicated in triggering apoptosis in cardiomyocytes.
- Exploration of interactions between apoptotic factors.
Main Results:
- Exaggerated apoptosis is suggested to cause cardiomyocyte loss in the hypertensive left ventricle.
- Both intrinsic and extrinsic factors are potential triggers for cardiomyocyte apoptosis.
- Interactions between these factors are under investigation.
Conclusions:
- Cardiomyocyte loss via apoptosis is a key factor in hypertensive heart disease progression.
- Identifying apoptotic triggers is essential for therapeutic strategies.
- Further research into factor interactions may prevent heart failure in hypertensive patients.
Abstract:
Numerous hypotheses have been considered to explain the fundamental mechanism(s) for the development of systolic dysfunction and heart failure in animals and humans with arterial hypertension. Besides contractile disturbances of cardiomyocytes and interstitial and perivascular fibrosis, cardiomyocyte loss is now being considered as one of the determinants of the maladaptive processes implicated in the transition from compensated to decompensated left ventricular hypertrophy. A number of experimental evidence suggest that exaggerated apoptosis may account for the loss of cardiomyocytes in the hypertensive left ventricle. Furthermore, some factors intrinsic and extrinsic to the cardiomyocyte emerge as potential candidates to trigger apoptosis. The elucidation of the possible interactions between these factors may be of major interest to prevent the progression to heart failure in patients with hypertensive heart disease.